Evidence map›Paper›PMID 34999111›Full record

ArticleMetabolism: clinical and experimental2022

Insulin regulates arginine-stimulated insulin secretion in humans.

Florencia Halperin, Teresa Mezza, Ping Li, Jun Shirakawa, Rohit N Kulkarni, Allison B Goldfine

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia.The Journal of clinical endocrinology and metabolism · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Florencia HalperinJoslin Diabetes Center, Boston, MA, United States of America; Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
Teresa MezzaJoslin Diabetes Center, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Endocrinologia e Diabetologia, Fondazione Policlinico Universitario A. Gemelli IRCSS, Roma, Italy; Università Cattolica del Sacro Cuore, Roma, Italy.
Ping LiJoslin Diabetes Center, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, PR China.
Jun ShirakawaJoslin Diabetes Center, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America; Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Maebashi, Japan.
Rohit N KulkarniJoslin Diabetes Center, Boston, MA, United States of America; Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: rohit.kulkarni@joslin.harvard.edu.
Allison B GoldfineJoslin Diabetes Center, Boston, MA, United States of America; Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: agoldfine@bwh.harvard.edu.
Brigham and Women's Hospital · USJoslin Diabetes Center · USUniversità Cattolica del Sacro Cuore · IT

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
The Role of Insulin Regulation of Beta Cell Function in Vivo & in VitroR01DK070648 · NIDDK · JOSLIN DIABETES CENTER · PI GOLDFINE, ALLISON B · 2005 to 2008
$1.4M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK070648
6 · The paper itself

Abstract

aimsInsulin potentiates glucose-stimulated insulin secretion. These effects are attenuated in beta cell-specific insulin receptor knockout mice and insulin resistant humans. This investigation examines whether short duration insulin exposure regulates beta cell responsiveness to arginine, a non-glucose secretagogue, in healthy humans. MATERIALS AND

methodsArginine-stimulated insulin secretion was studied in 10 healthy humans. In each subject arginine was administered as a bolus followed by continuous infusion on two occasions one month apart, after sham/saline or hyperinsulinemic-isoglycemic clamp, respectively providing low and high insulin pre-exposure conditions. Arginine-stimulated insulin secretion was measured by C-peptide deconvolution, and by a selective immunogenic (DAKO) assay for direct measurement of endogenous but not exogenous insulin.

resultsPre-exposure to exogenous insulin augmented arginine-stimulated insulin secretion. The effect was seen acutely following arginine bolus (endogenous DAKO insulin incremental AUC

conclusionsWe demonstrate a physiologic role of insulin in regulation of the beta cell secretory response to arginine.

Indexed as

AdultArginineBlood GlucoseC-PeptideFemaleHumansInsulinInsulin-Secreting CellsInsulin SecretionMaleYoung AdultArginineBlood GlucoseC-PeptideInsulinArginineBeta cell regulationInsulin resistanceInsulin secretion

Identifiers

PMID34999111
PMCPMC8821403
OpenAlexW4205817659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.